Comparison of Two Different Concentrations of Local Anesthetic in Patient Reported Pain in Oculoplastic Surgery

NCT06121141 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-09-20

No results posted yet for this study

Summary

The goal of this clinical trial is to compare pain scores in people undergoing upper eyelid surgery. The main questions it aims to answer are:

* Is one concentration of local anesthetic (also called numbing or freezing injection) less painful when it is injected?
* Does one concentration of local anesthetic provide better pain control during surgery? Participants will have two different concentrations of local anesthetic injected into the upper eyelid skin prior to surgery, and will be asked to rate the pain they have during the injection. At the end of surgery, they will be asked to rate the pain they have during surgery.

Researchers will compare the pain scores to see if one of the concentrations is less painful during the injection and to see if one of the concentrations provides better pain control during surgery.

Conditions

  • Dermatochalasis
  • Dermatochalasis of Eyelid
  • Dermatochalasis of Both Upper Eyelids
  • Dermatochalasis of Both Eyes
  • Dermatochalasis of Right Upper Eyelid
  • Dermatochalasis of Left Upper Eyelid
  • Pain

Interventions

DRUG

Full strength lidocaine with epinephrine

2% lidocaine with epinephrine 1:100,000

DRUG

Dilute lidocaine with epinephrine

2% lidocaine with epinephrine 1:100,000 diluted with normal saline (09.% NaCl) in a 1:4 ratio

Sponsors & Collaborators

  • Timothy Ekhlassi

    lead OTHER

Principal Investigators

  • Timothy Ekhlassi, MD · Fraser Valley Cataract and Laser

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-07
Primary Completion
2024-01-23
Completion
2024-05-27
FDA Drug
Yes

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121141 on ClinicalTrials.gov